Abstract 10195: Comparing the Antiplatelet and Antithrombotic Effects of CCG263719 and SLUG001, Second Generation 12-Lipoxygenase Inhibitors, to ML355
Background: Platelet-mediated thrombosis is a major contributor to myocardial infarction and other cardiovascular diseases. Reperfusion following ischemia can further exacerbate tissue injury, in part through platelet activation and inflammatory signaling. Platelet 12(S)-lipoxygenase (12-LOX), an oxygenase that prom...